KIO-101
KIO-101-2201
Phase 2 small_molecule terminated
Quick answer
KIO-101 for Dry Eye Disease is a Phase 2 program (small_molecule) at KIORA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KIORA PHARMACEUTICALS INC
- Indication
- Dry Eye Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated